Company Overview of UCB, Inc.
UCB, Inc. operates as a research-based pharmaceutical company. It develops products to treat diseases of the central nervous system and immunological disorders. The company’s products include Cimzia that is used for the treatment of rheumatoid arthritis in adults; Vimpat, an oral solution used for adjunctive therapy in the treatment of partial-onset seizures in patients 17 years of age and older; and Neupro, which is used for the treatment of signs and symptoms of idiopathic Parkinson's disease. Its products also include Keppra XR that is used as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy; Metadate CD, a solution that is ...
1950 Lake Park Drive SE
Smyrna, GA 30080
Founded in 1994
Key Executives for UCB, Inc.
Vice President of Investor Relations
Vice President of Global Communications
Compensation as of Fiscal Year 2014.
UCB, Inc. Key Developments
UCB, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013
Feb 7 13
UCB, Inc. Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 . Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries